Chronic spine pain is one of the most common and conditions in adults over the age of 65. Treatments for pain that are non-pharmacologic (do not use over-the-counter or prescription drugs) are recognized as some of the most important to study. Chiropractic care has shown to be effective at reducing chronic pain, and growing research supports the use of group visit programs for the management of chronic pain. There is reason to believe that combining the two could enhance the benefit previously demonstrated by these treatments individually. There are no studies that have examined the combined delivery of chiropractic care and group visit programs for adults over the age of 65. The investigators plan assess the feasibility of treating adults over the age of 65 with chronic spine pain with chiropractic care and a group visit program. A battery of biopsychosocial outcomes will be collected to inform a more definitive trial.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
10
Chiropractic treatment will involve a personalized treatment plan within the context of a general care protocol administered by a chiropractor at the Osher Clinical Center for Integrative Health. The treatment plan will be customized to the patient's clinical needs following the current evidence and clinical practice guidelines.
Participants will simultaneously enroll in virtual group medical visits with group discussion, practice based learning, and curricular themes pertaining to chronic pain management, healthy aging, and pillars of lifestyle medicine.
MassGeneralBrigham
Boston, Massachusetts, United States
RECRUITINGRecruitment
Recruitment will be evaluated by tracking the recruitment source of participants, the number of participants enrolled per week overall, the reasons that screened individuals were not eligible, and the number of individuals deciding not to be screened, or if screened, why they are not interested in enrolling. Recruitment is estimated to be 10 total participants.
Time frame: Prior to intervention initiation
Retention
Retention will be quantified by the proportion of participants who complete all outcome assessments at the end of the intervention period. We will consider future testing of our interventions if the expected proportion of participants to have completed primary outcome assessments is least 70%.
Time frame: Monitored weekly throughout 8-week intervention period
Adherence
Adherence will be calculated as the proportion of participants who attend at least 6 of the 8 chiropractic care visits and 6 of the 8 of virtual group visits. We will consider future testing of our interventions if the expected proportion of participants judged to be adherent to the intervention is at least 70%.
Time frame: Monitored weekly throughout 8-week intervention period
Satisfaction with interventions
Satisfaction will be calculated as the proportion of participants who report satisfaction with the program. We will consider future testing of our interventions if the expected proportion of participants who report satisfaction is at least 70%.
Time frame: Measured at 8-week study visit
Pain intensity
Pain intensity will be measured using a 11-point numerical rating scale (NRS) with 0 indicating "no pain at all" and 10 indicating "worst pain imaginable".
Time frame: Measured at baseline and 8-week study visit
Oswestry Disability Index
Pain-related disability will be measured using the Oswestry Disability Index (ODI). These 10-item questionnaires determine how participants see their pain affecting their daily activities. The maximum score is 100%. Scores of \<8% indicate no disability; 10% to 28% indicate mild disability, 30% to 48% moderate disability, and 50% to 68% severe disability. Scores \>70% indicate a complete perceived disability.
Time frame: Measured at baseline and 8-week study visit
PROMIS-29
PROMIS 29 is a system of validated, highly reliable, precise measures of patient-reported health status for physical, mental, and social well-being. In addition to pain intensity and pain interference, this set of measures includes physical function, fatigue, depressive symptoms, anxiety, ability to participate in social roles and activities, and sleep disturbance.Raw scores are extracted and converted to T-scores on all subscales. Items are scored from 1 to 5, with a higher score indicating a higher degree of the construct being measured. The T-score metric used for data analysis uses a mean of 50 and a standard deviation of 10 in the U.S. population.
Time frame: Measured at baseline and 8-week study visit
Self-efficacy
Self-efficacy will be measured using the General Self-Efficacy Scale (GSES). The GSES measures a participant's confidence in their ability to respond to environmental demands and challenges. The scale consists of 10 items with a 4-point Likert response scale ranging from 1 ("not at all true") to 4 ("exactly true"). Higher summed scores indicate greater self-efficacy to complete tasks.
Time frame: Measured at baseline and 8-week study visit
Locus of control
Locus of control will be measured using the Internal-External Locus of Control short Scale-4 (IE-4). The IE-4 measures two dimensions of the locus of control (internal and external) with two items each. Each statement consists of a 5-point Likert scale with responses ranging from 1 ("doesn't apply at all") to 5 ("applies completely"). Higher scores in the first two items indicate an internal locus of control, while higher scores in the second two items indicate an external locus of control.
Time frame: Measured at baseline and 8-week study visit
Pain catastrophizing
Pain Catastrophizing Scale used to assess catastrophic thinking associated with pain. This instrument consists of 13 items that measure rumination, magnification, and helplessness related to pain and has adequate to excellent internal consistency, with higher scores representing more of the item tested.
Time frame: Measured at baseline and 8-week study visit
Fear of Movement
Fear of Movement will be measured using the Tampa Scale for Kinesiophobia. This instrument consists of 17 items that measure pain-related fear and has been validated in chronic low back pain and fibromyalgia patients. Higher scores represent more fear of movement.
Time frame: Measured at baseline and 8-week study visit
Social Support
Social Support will be measured with the Multidimensional Scale of Perceived Social Support (MSPSS) which measures an individual's perception of support from family, friends, and a significant other. It consists of 12 items with lower scores indicating low perceived support, and higher scores indicating higher perceived support.
Time frame: Measured at baseline and 8-week study visit
Short Physical Performance Battery (SPPB)
The SPPB measures lower extremity physical performance status including balance, gait speed, and chair stands and has been linked to mortality and disability. Gait speed, contained in the SPPB, will be assessed using the ZenoTM Walkway, developed by ProtoKinetics (https://www.protokinetics.com). The portable 2' X 20' gait walkway and associated hardware system can be easily assembled for use in a clinical setting (e.g., hallway), and comes with laptop computer with sophisticated, but user-friendly software (PKMAS). Gait data is collected by simply having the patient walk across an electronic gait mat. A series of gait parameters automatically calculated by ZENOTM will be captured including walking speed and stride time variability.
Time frame: Measured at baseline and 8-week study visit
Qualitative interviews
Qualitative interviews will be employed to further probe participants' perceptions of the combined interventions focusing on a) understanding facilitators and barriers to participation, and b) patient-centered experiences that might inform outcome measures to use in a future trial.
Time frame: Measured at baseline and 8-week study visit
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.